- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 08.11. | Nkarta continues pivot to autoimmune by shelving lymphoma program for CAR NK candidate | ||
| 08.11. | Chutes & Ladders-Trevena teeters on edge with C-suite shakedown | ||
| 08.11. | NextCure goes all in on B7-H4, stopping other programs to challenge Big Pharma in ADC space | ||
| 08.11. | Allogene links off-the-shelf CAR-T to responses and 3 deaths in phase 1 solid tumor trial | ||
| 07.11. | J&J MedTech secures FDA approval for Varipulse pulsed field ablation system | ||
| 07.11. | VC Aditum Bio hatches autoimmune-focused Oblenio Bio with asset from Chinese biotech | ||
| 07.11. | Trevena teeters in dangerous territory, terminating CEO and other execs amid strategic review | ||
| 07.11. | Rapport's attempt to test epilepsy drug in nerve damage placed on hold by FDA | ||
| 07.11. | ADC Therapeutics axes lead solid tumor drug after phase 1 setback, pivots to preclinical programs | ||
| 07.11. | Sarepta axes late-phase DMD drug over safety signal, FDA talks | ||
| 07.11. | Celldex drops phase 1 solid tumor bispecific to focus on inflammation | ||
| 07.11. | Genmab axes 3 programs to focus on plumped up pivotal pipeline | ||
| 07.11. | Viracta begins 2nd round of layoffs in 3 months to keep lymphoma program afloat | ||
| 06.11. | Charles River continues slide in Q3 as CEO spots reduced spending by biopharma clients | ||
| 06.11. | Boundless Bio drug shrinks tumors in mice by targeting extrachromosomal DNA | ||
| 06.11. | FDA clears first treatment for dry AMD, with LumiThera's light-based Valeda system | ||
| 06.11. | Ring Therapeutics calls on Singapore research agencies for gene therapy R&D partnership | ||
| 06.11. | Acadia to make $100M profit from selling pediatric review voucher for $150M | ||
| 06.11. | Tango has last dance with PRMT5 inhibitor, pirouettes into embrace with 2 sibling molecules | ||
| 06.11. | Novo Nordisk discards kidney disease drug from $1.3B deal in wake of phase 3 fail | ||
| 06.11. | CMS hands Medicare coverage to renal denervation systems from Medtronic, Recor Medical | ||
| 06.11. | MacroGenics pauses work on vobra duo ADC pending mature survival data | ||
| 05.11. | Medidata meshes services into bundles for oncology and vaccine clinical trials | ||
| 05.11. | ASH: New Gilead-Arcellx data build CAR-T's case against Carvykti in advanced multiple myeloma | ||
| 05.11. | Inquis Medical draws up $40M to fund blood clot removal system |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
